.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Healthtrust
Boehringer Ingelheim
QuintilesIMS
Medtronic
Deloitte
Johnson and Johnson
Teva
McKesson
Julphar

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017016

« Back to Dashboard
NDA 017016 describes CHORIONIC GONADOTROPIN, which is a drug marketed by Ferring, Bel Mar, and Fresenius Kabi Usa, and is included in three NDAs. It is available from two suppliers. Additional details are available on the CHORIONIC GONADOTROPIN profile page.

The generic ingredient in CHORIONIC GONADOTROPIN is gonadotropin, chorionic. Four suppliers are listed for this compound. Additional details are available on the gonadotropin, chorionic profile page.

Summary for NDA: 017016

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017016

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHORIONIC GONADOTROPIN
gonadotropin, chorionic
INJECTABLE;INJECTION 017016 NDA Ferring Pharmaceuticals Inc. 55566-1501 55566-1501-1 1 KIT in 1 CARTON (55566-1501-1) * 1 INJECTION in 1 VIAL * 10 mL in 1 VIAL (55566-1700-0)
CHORIONIC GONADOTROPIN
gonadotropin, chorionic
INJECTABLE;INJECTION 017016 NDA Ferring Pharmaceuticals Inc. 55566-1502 55566-1502-1 1 KIT in 1 CARTON (55566-1502-1) * 1 INJECTION in 1 VIAL * 10 mL in 1 VIAL (55566-1700-0)

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength20,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 006

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 007

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Accenture
Covington
Fish and Richardson
Federal Trade Commission
UBS
Teva
Harvard Business School
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot